Your Catalyst to a Lucrative Business
Browse Details of Report @ https://www.hexaresearch.com/research-report/doxorubicin-market
Media is also playing an important role in spreading awareness about various diseases and related
drugs. Consumer awareness of these drugs is expected to have a positive impact on the doxorubicin
market. Support from non-profit organizations and regional government in UK on approval of drugs is
anticipated to drive the market during the forecast period.
However, Doxorubicin therapy can cause a risk of developing leukemia and tumor lysis syndrome
which can further lead to kidney failure is expected to act as a roadblock for the growth of doxorubicin
market. This drug also has adverse effects and can cause skin rashes, itchy sensation, can lead
patient feel short of breath, swelling of face, feeling dizzy and stomach ache. Moreover, it can cause
extensive tissue damage and can develop dizziness among consumer. High treatment cost poses a
challenge to this market. Also, pharmaceutical industries significantly rely on the R&D initiatives.
Pharmaceutical agencies are focusing on new medicines in order to cater to the customer needs which
may poses as a threat to this market in the long run.
The market can be segmented on the basis of cancer type. Doxorubicin treats number of cancers such
as acute lymphoblastic leukemia, acute myeloblastic leukemia, bone sarcoma, breast cancer,
endometrial cancer, gastric cancer, head and neck cancer, liver cancer, kidney cancer, ovarion cancer,
small cell lung cancer, thyroid cancer and transitional cell bladder cancer. Drug used for treating
thyroid cancer dominated the market in the recent past on account of growing incidences of thyroid
cancer especially in UK.
The U.S. dominated the market in the near past on account approval of doxorubicin products by FDA
and increasing number of cancer incidences. Europe is one of the major markets owing to increasing
number of deaths due to cancer. Emerging nations such as India and China are anticipated to show a
substantial growth rate based on the growing population, cancer incidences and tobacco consumption.
Africa is expected to observe a lower growth rate owing to lack of consumer awareness and healthcare
infrastructure, and expensive medication.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-
industry
Follow Us: